2013
DOI: 10.4314/ahs.v13i2.4
|View full text |Cite
|
Sign up to set email alerts
|

Proposed guidelines for the management of nodding syndrome

Abstract: Nodding Syndrome is a poorly understood neurologic disorder of unknown aetiology that affects children and adolescents in Africa. Recent studies have suggested that the head nods are due to atonic seizures and Nodding Syndrome may be classified as probably symptomatic generalised epilepsy. As part of the Ugandan Ministry of Health clinical management response, a multidisciplinary team developed a manual to guide the training of health workers with knowledge and skills to manage the patients. In the absence of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
72
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(73 citation statements)
references
References 31 publications
0
72
0
1
Order By: Relevance
“…24 On the basis of some theoretical considerations, sodium valproate (VPA) was proposed as an AED that might be most appropriate for controlling the presumably myoclonic movements of head nodding seizures. 26 However, only limited data on the use of VPA in NS are available 7,27 and these do not indicate the greater efficacy of VPA over the alternative AEDs already mentioned. In view of the possibly severe adverse effects of VPA, [28][29][30] the high cost and its difficult availability in rural Africa, it might be reconsidered to abide by the general WHO recommendation to use PHB as the first-line drug, 31,32 especially in patients with coexisting head nodding and convulsive seizures.…”
Section: Discussionmentioning
confidence: 99%
“…24 On the basis of some theoretical considerations, sodium valproate (VPA) was proposed as an AED that might be most appropriate for controlling the presumably myoclonic movements of head nodding seizures. 26 However, only limited data on the use of VPA in NS are available 7,27 and these do not indicate the greater efficacy of VPA over the alternative AEDs already mentioned. In view of the possibly severe adverse effects of VPA, [28][29][30] the high cost and its difficult availability in rural Africa, it might be reconsidered to abide by the general WHO recommendation to use PHB as the first-line drug, 31,32 especially in patients with coexisting head nodding and convulsive seizures.…”
Section: Discussionmentioning
confidence: 99%
“…Children with NS are often underweight and malnourished, (Idro et al . ) but this could also be a consequence of the condition rather than due to malnutrition.…”
Section: Research Progress Since 2012mentioning
confidence: 99%
“…As the publication of a WHO report and potential management guidelines (WHO ; Idro et al . ), many more scientists have tried to describe or define the disease and to adapt its appearance to regional or local concepts. The resulting ideas and novel descriptions of pathogenic mechanisms give rise to discussions and controversies (van der Waals et al .…”
mentioning
confidence: 99%